Australia markets closed

OncoSil Medical Limited (OSL.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0040-0.0010 (-20.00%)
At close: 04:10PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
239.308
367.677
231.789
213.07
-
Cost of revenue
1,872
1,589
972.474
961.023
-
Gross profit
-1,633
-1,221
-740.685
-747.953
-
Operating expenses
Research development
2,689
2,851
2,376
2,888
3,726
Selling general and administrative
6,371
6,689
7,170
6,652
1,701
Total operating expenses
11,371
11,508
10,796
11,064
7,359
Operating income or loss
-13,004
-12,729
-11,536
-11,812
-7,359
Interest expense
-
0.005
-
1.081
0.861
Total other income/expenses net
1,019
1,159
692.11
1,127
2,854
Income before tax
-11,707
-11,343
-10,727
-10,434
-4,262
Income tax expense
0
0
0
0
0
Income from continuing operations
-11,707
-11,343
-10,727
-10,434
-4,262
Net income
-11,707
-11,343
-10,727
-10,434
-4,262
Net income available to common shareholders
-11,707
-11,343
-10,727
-10,434
-4,262
Basic EPS
-0.01
-0.01
-0.01
-0.01
-0.01
Diluted EPS
-0.01
-0.01
-0.01
-0.01
-0.01
Basic average shares
1,129,593
1,129,593
997,878
1,019,231
817,510
Diluted average shares
1,129,593
1,129,593
997,878
1,019,231
817,510